Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Shretta, Rima ^a   Yadav, Prashant ^b  

^a Systems for Improved Access to Pharmaceuticals Services   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Artemisinin; Artemisinin based combination therapy (ACT); Buffer stock; Financial buffers; Physical buffers; Safety stock

Indexed keywords

ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTESUNATE; DIHYDROARTEMISININ;

DRUG COST; DRUG UTILIZATION; FINANCIAL MANAGEMENT; FUNDING; HEALTH CARE AVAILABILITY; HEALTH CARE NEED; HUMAN; REVIEW; WORLD HEALTH ORGANIZATION;

ANTIMALARIALS; ARTEMISININS; DRUG COSTS; DRUG INDUSTRY; DRUG THERAPY, COMBINATION; HUMANS; MALARIA; WORLD HEALTH;

EID: 84870203643     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-399     Document Type: Review

References (53)

1. WHO, WHO Urges Countries to Act on New Anti-Resistance Malaria Medicines Geneva: World Health Organization 2002 [ https://apps.who.int/inf/en/pr-2002-31. html ]
2. WHO, Global supply of artemether-lumefantrine before, during, and after the Memorandum of Understanding between WHO and Novartis. May, 2011 Geneva: World Health Organization 2012 [ http://www.who.int/malaria/diagnosis-treatment/ finance/MoU-termination-report.pdf ]
3. Grace C, Grupper M, Aligning ACT Supply and Demand: Short and Long Term Options. London: DFID Health Systems Resource Centre London: Department for International Development 2005
4. WHO, World Malaria Report 2011 Geneva: World Health Organization 2012 [ http://www.who.int/malaria/world-malaria-report-2011/en/ ]
5. Harrison TP, Lee HL, Neale JJ, The practice of supply chain management: where theory and application converge USA: Springer 2005
6. UNITAID, Demand Forecast for Artemisinin-based Combination Therapies (ACTs) in 2012-2013 Q2-2012 Update. Prepared by the ACT Forecasting Consortium Geneva: UNITAID 2012 http://www.unitaid.eu/images/projects/malaria/ACT- Forecasting/ACT-Forecasting-Update-Q2-2012%20-25-July-12.pdf
7. WHO, ACT Supply Task Force: Report to RBM Board. 2011 Geneva: World Health Organization 2012 [ http://www.who.int/hiv/events/malaria-task-force- silvia2.pdf ]
8. Dalberg Global Development Advisors, Independent Mid-Term Review of the Assured Artemisinin Supply System (A2S2) Project Geneva: UNITAID 2012 [ http://www.unitaid.eu/images/projects/malaria/110406-A2S2-Final-Report.pdf ]
9. Assured Artemisinin Supply System, Launch of "Assured Artemisinin Supply System (A2s2)" Initiative 2009 2012 http://www.a2s2.org/assets/ files/Briefing-industry-v5.0.doc 23344386
10. RBM/UNITAID/WHO, Artemisinin Conference Final Report Hanoi, Vietnam 2011 [ http://www.mmv.org/sites/default/files/uploads/docs/events/2011/2011- Artemisinin-Conference-Report.pdf ]
11. Ensuring sustained ACT production and reliable artemisinin supply. Kindermans JM, Pilloy J, Olliaro P, Gomes M, Malar J 2007 6 125 10.1186/1475-2875-6-125 17868471 (Pubitemid 47561490)
12. Yadav P, Smith L, Alphs S, Assessment of the effects of the Affordable Medicines Facility-malaria (AMFm) on market dynamics of API and ACTs at the global level Ann Arbor, USA: University of Michigan Technical Report. William Davidson Institute. 2012
13. WHO, List of Prequalified Medicinal Products Geneva: World Health Organization 2012 [ http://apps.who.int/prequal/query/ProductRegistry.aspx?list= ma ]
14. Dalrymple DG, Artemisia annua, Artemisinin, ACTs and Malaria Control in Africa: The Interplay of Tradition, Science and Public Policy, Working Paper Geneva: Medicines for Malaria Venture 2012 [ http://www.mmv.org/sites/default/ files/uploads/docs/publications/ Artemisia%20annua%20Artemisinin%20ACTS%20and%20Malaria%20control%20in%20Africa. Sept20.pdf ]
15. Spar D, Delacey BJ, The Coartem Challenge Boston, MA: Harvard Business School Publishing A), Harvard Business School Case Study 9-706-037. 2008
16. Spar D, The Coartem Challenge Boston, MA: Harvard Business School Publishing (B), Harvard Business School Case Study 9-707-025. 2008
17. WSJ, Clinton Foundation Sets Up Malaria-Drug Price Plan New York: Wall Street Journal 2008
18. A2S2, Assured Artemisinin Supply System Woerden 2012 [ http://www.a2s2.org/index.php?id=76 ]
19. Strengthening Pharmaceutical Systems, A New Medicine Monitoring System Helps Prevent Antimalarial Stock-Outs in the Americas Region. Strengthening Pharmaceutical Systems Program Arlington, VA: Management Sciences for Health 2011
20. Supply Chain Management Solutions, Coordinated Procurement Planning Initiative Geneva: World Health Organization 2012 http://who.int/hiv/amds/scms- cpp-initiative. pdf
21. Equity and adequacy of international donor assistance for global malaria control: an analysis of populations at risk and external funding commitments. Snow RW, Okiro EA, Gething PW, Atun R, Hay SI, Lancet 2010 376 1409 1416 10.1016/S0140-6736(10)61340-2 20889199
22. Malaria subsidy pilot soars, but some see turbulence ahead. Maxmen A, Nat Med 2012 18 634 635 10.1038/nm0512-634 22561803
23. Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies. Cohen JM, Singh I, O'Brien ME, Malar J 2008 7 200 10.1186/1475-2875-7-200 18831742
24. Absorptive capacity and disbursements by the Global Fund to Fight AIDS, Tuberculosis and Malaria: analysis of grant implementation. Lu C, Michaud CM, Khan K, Murray CJ, Lancet 2006 368 483 488 10.1016/S0140-6736(06)69156-3 16890835 (Pubitemid 44142770)
25. Global Fund grant programmes: an analysis of evaluation scores. Radelet S, Siddiqi B, Lancet 2007 369 1807 1813 10.1016/S0140-6736(07)60818-6 17531888 (Pubitemid 46783019)
26. Shretta R, Global Fund Grants for Malaria: Summary of Lessons Learned in the Implementation of ACTs in Ghana, Nigeria, and Guinea-Bissau Arlington, VA: Management Sciences for Health US Agency for International Development by the Rational Pharmaceutical Management Plus Program. 2007
27. Dhingra N, Review of Global Fund Round 8 Malaria Grant Signatures in 14 Sub-Saharan African Countries Geneva: Roll Back Malaria Partnership 2009
28. Global Fund, Board Approves Integration of AMFm into Core Global Fund Grant Processes Geneva: The Global Fund News Release 2012 [ http://www.org/ theglobalfunden/mediacenter/newsreleases/2012-11-15-Board-Approves-Integration- of-AMFm-into-Core-Global-Fund-Grant-Processes/ ]
29. Rockwood J, LLIN Bottleneck Questionnaire-Updated Findings, RBM/Global Fund LLIN Procurement and Supply Management Workshop Geneva: Roll Back Malaria Partnership 2009
30. The Global Fund Office of the Inspector General, Audits and Investigations Geneva: The Global Fund 2012 http://www.theglobalfund.org/en/oig/ reports/
31. Time for a "third wave" of malaria activism to tackle the drug stock-out crisis. Editorial, PLoS Med 2009 6 1000188 19936043
32. Impact of national malaria control scale-up programmes in Africa: magnitude and attribution of effects. Steketee RW, Campbell CC, Malar J 2010 9 299 10.1186/1475-2875-9-299 20979634
33. Strengthening Pharmaceutical Systems, Manual for Quantification of Malaria Commodities: Rapid Diagnostic Tests and Artemisinin-Based Combination Therapy for First-Line Treatment of Plasmodium Falciparum Malaria Arlington, VA: Management Sciences for Health Strengthening Pharmaceutical Systems Program. 2012
34. Regional group purchasing of vaccines: review of the Pan American Health Organization EPI revolving fund and the Gulf Cooperation Council group purchasing program. DeRoeck D, Bawazir SA, Carrasco P, Kaddar M, Brooks A, Fitzsimmons J, Andrus J, Int J Health Plann Manage 2006 21 23 43 10.1002/hpm.822 16604847
35. Center for Pharmaceutical Management, Regional Pooled Procurement of Drugs: Evaluation of Programs Arlington, VA: Management Sciences for Health 2002
36. Burnett F, Reducing costs through regional pooled procurement, Essential Drugs Monitor 2003, Volume 32 Geneva: World Health Organization 2003 7 8
37. Global Fund, Global Fund Board Decision Point GF/B23/DP9 Geneva: The Global Fund 2012 [ http://www.theglobalfund.org/documents/board/23/BM23- DecisionPointsValueForMoneyMarketShaping-Report-en/ ]
38. Yadav P, Curtis K, Sekhri N, Mapping and realigning incentives in the global health supply chain: based on the supply chain for artemisinin combination therapy treatments for malaria Zaragoza, Spain: MIT-Zaragoza International Logistics Program and the Healthcare Redesign Group Inc 2006 [ http://www.cgdev.org/doc/DemandForecasting/RealigningIncentives.pdf ]
39. Yadav P, Sekhri N, Curtis KA, Barriers to Access: An Assessment of Stakeholder Risks and Incentives in the Value Chain for Artemisinin Combination Therapy (ACT) Treatments (June 2007) Social Sciences Research Network 2012 [ http://dx.doi.org/10.2139/ssrn.1008307 ]
40. Demand forecasting for essential medical technologies. Levine R, Pickett J, Sekhri N, Yadav P, Am J Law Med 2008 34 2 3
41. "Supply Contracts with Quantity Commitments and Stochastic Demand" Anupindi R, Bassok Y, Quantitative Models for Supply Chain Management Boston, MA: Kluwer Academic Publishers, Tayur S, Magazine M, Ganeshan R, 1999
42. WHO, WHO Consultation on oral cholera vaccine (OCV) stockpile strategic framework: potential objectives and possible policy options Geneva: World Health Organization 2011 http://whqlibdoc.who.int/hq/2012/WHO-IVB-12.05-eng.pdf
43. UNICEF, Supplies and Logistic. Vaccine Security Copenhagen: United Nations Children's Fund 2012 [ http://www.unicef.org/supply/index-vaccine- security.html ]
44. UNICEF, Annual Supply Report 2010 Copenhagen: United Nations Children's Fund 2012 [ http://www.UNICEF.org/supply/files/UNICEF-Supply-Annual-Report-2010- web.pdf ]
45. UNICEF, Tender Strategy and Timeline [PowerPoint slides]. 2010 Copenhagen: United Nations Children's Fund 2012 [ http://www.unicef.org/supply/ files/OPVTenderStrategy.pdf ]
46. Vargas A, Yadav P, Evaluating the Costs and Benefits of Regional Distribution Hubs for HIV/AIDS Zaragoza, Spain: MIT-Zaragoza Working Paper 2009
47. SCMS, Regional Distribution Centers and Inventory Management Arlington, VA: SCMS Technical Brief 2010 Supply Chain Management Systems 2012 [ http://scms.pfscm.org/portal/pls/portal/!PORTAL.wwpob-page.show?-docname= 2195390.PDF ]
48. I+Solutions, ARV Access for Africa (AA4A) Woerden: I+Solutions 2012 [ http://www.iplussolutions.org/index.php?id=6 ]
49. President's Malaria Initiative, Working with Communities to Save Lives in Africa Third Annual Report Washington DC: USAID 2009
50. WHO Stop TB Department, Drug Resistant TB: Quarterly Newsletter of the Multidrug Resistant TB Working Group. 2008 Geneva: World Health Organization 2012 [ http://www.stoptb.org/wg/mdrtb/assets/documents/ MDR%20TB%20Newsletter%20April.pdf ]
51. United Nations Foundation, The Pledge Guarantee for Health Washington, DC: United Nations Foundation 2012 [ http://www.unfoundation.org/what-we-do/ campaigns-and-initiatives/pledge-guarantee-for-health/ ]
52. Microbially derived artemisinin: a biotechnology solution to the global problem of access to affordable antimalarial drugs. Hale V, Keasling JD, Renninger N, Diagana TT, AmJTrop Med Hyg 2007 77 198 202
53. ITC's e-Choupal: A platform strategy for rural transformation. Anupindi R, Sivakumar S, Business solutions for the global poor: Creating social and economic value San Francisco, CA: Jossey-Bass, Kasturi Rangan V, Quelch JA, Herrero G, Barton B, 2007 173 182